Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Elanco Animal Health ( (ELAN) ) just unveiled an announcement.
On June 25, 2025, Elanco Animal Health Incorporated, along with Elanco SPEAR LLC and Elanco US Inc., amended its Receivables Loan Agreement with Rabobank, extending the term of the agreement to June 26, 2028. This amendment impacts the company’s accounts receivable securitization facility, potentially affecting its financial obligations and operational flexibility.
The most recent analyst rating on (ELAN) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Elanco Animal Health stock, see the ELAN Stock Forecast page.
Spark’s Take on ELAN Stock
According to Spark, TipRanks’ AI Analyst, ELAN is a Outperform.
Elanco Animal Health’s overall stock score is driven by strong financial performance and bullish technical indicators. The company’s solid earnings call results and strategic corporate changes further enhance its growth prospects. However, valuation concerns and external challenges like tariffs temper the score.
To see Spark’s full report on ELAN stock, click here.
More about Elanco Animal Health
Elanco Animal Health Incorporated operates in the animal health industry, focusing on the development and supply of products and services for animal health and well-being.
Average Trading Volume: 6,235,584
Technical Sentiment Signal: Buy
Current Market Cap: $6.83B
For an in-depth examination of ELAN stock, go to TipRanks’ Overview page.